Literature DB >> 31786287

Bicuspidization and Annuloplasty Provide a Functioning Configuration to the Unicuspid Aortic Valve.

Takashi Igarashi1, Shunsuke Matsushima1, Atsushi Shimizu1, Tristan Ehrlich1, Irem Karliova1, Hans-Joachim Schäfers2.   

Abstract

BACKGROUND: This study reviewed a 12-year experience with a bicuspidization procedure that created a new commissure and added a patch for unicuspid aortic valve repair.
METHODS: All patients with a unicuspid aortic valve who underwent bicuspidization with autologous pericardium between 2003 and 2014 were evaluated. The new commissure had initially been created on the rudimentary anterior commissure, and since 2007, symmetric orientation was designed. Suture external annuloplasty was introduced after 2009 for basal ring dilatation.
RESULTS: There were 137 consecutive patients. The median age at operation was 26 years (range, 3 to 64 years). Aortic regurgitation, aortic stenosis, and combined aortic regurgitation and stenosis were present in 68 (50%), 15 (11%), and 54 (39%) patients, respectively. A total of 71 patients were operated on after 2009. Annuloplasty was added in 47 patients. There were 2 early and 3 late deaths. Overall survival was 96% at 10 years. A total of 47 patients required aortic valve reoperation because of patch degeneration (n = 20), suture dehiscence of patch (n = 17), and other causes (n = 10). Freedom from aortic valve reoperation was 77% and 59% at 5 and 10 years, respectively, and 82% and 75% at 5 and 8 years in patients operated on after 2009, respectively. Suture dehiscence of the patch occurred significantly more often in patients with a basal ring diameter of 28 mm or larger before 2009 (38% in 5 years), and it decreased significantly with annuloplasty (9% in 5 years).
CONCLUSIONS: Bicuspidization and annuloplasty create a functioning valve configuration in unicuspid aortic valve repair. Patch degeneration remains the main cause of reintervention and is the limiting factor for durability.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31786287     DOI: 10.1016/j.athoracsur.2019.10.023

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Narrative review of the contemporary surgical treatment of unicuspid aortic valve disease.

Authors:  Maria von Stumm; Tatjana Sequeira-Gross; Johannes Petersen; Shiho Naito; Lisa Müller; Christoph Sinning; Evaldas Girdauskas
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  Ross operation after failure of aortic valve repair.

Authors:  Karen B Abeln; Vincent Chauvette; Nancy Poirier; Shunsuke Matsushima; Ismail El-Hamamsy; Hans-Joachim Schäfers
Journal:  Ann Cardiothorac Surg       Date:  2021-07

3.  Structural Isomerism of the Aortic Valve: Bicuspidization Redux.

Authors:  Thomas G Gleason
Journal:  Ann Thorac Surg       Date:  2019-12-19       Impact factor: 4.330

4.  A successful repair of pentacuspid aortic valve.

Authors:  Tatsuo Motoki; Yuki Ikeno; Yasuo Suehiro; Atsushi Kurushima; Yutaka Okita; Yoshiaki Fukumura
Journal:  JTCVS Tech       Date:  2022-04-22

5.  Early results of geometric ring annuloplasty for bicuspid aortic valve repair during aortic aneurysm surgery.

Authors:  Marc W Gerdisch; T Brett Reece; Dominic Emerson; Richard S Downey; Geoffrey B Blossom; Arun Singhal; Joshua N Baker; Theodor J M Fischlein; Vinay Badhwar
Journal:  JTCVS Tech       Date:  2022-06-09

6.  Comparison of bicuspidization and Ross procedure in the treatment of unicuspid aortic valve disease in adults - Insight from the AVIATOR registry.

Authors:  Ján Gofus; Mikita Karalko; Petr Fila; Jiří Ondrášek; Hans-Joachim Schäfers; Adrian Kolesár; Emmanuel Lansac; Ismail El-Hamamsy; Laurent de Kerchove; Christian Dinges; Jaroslav Hlubocký; Petr Němec; Martin Tuna; Jan Vojáček
Journal:  Front Cardiovasc Med       Date:  2022-09-08

Review 7.  Which Aortic Valve Can Be Surgically Reconstructed?

Authors:  Karen B Abeln; Christian Giebels; Tristan Ehrlich; Jan M Federspiel; Hans-Joachim Schäfers
Journal:  Curr Cardiol Rep       Date:  2021-07-02       Impact factor: 2.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.